CJC-1295 with DAC 5 mg
49,90 €
CJC-1295 with DAC 5 mg is a synthetic long-acting GHRH research peptide supplied as a lyophilized powder. It contains a drug-affinity-complex modification and is studied in connection with GHRH receptor signaling, albumin association, sustained peptide exposure and growth-hormone-axis research.
Key product information:
- Compound: CJC-1295 with DAC
- Amount: 5 mg
- Form: Lyophilized powder
- Class: Long-acting DAC-modified GHRH analog
- Intended use: Research use only
- Description
- Additional information
Description
A GHRH Peptide Designed to Last Longer
Natural peptide signals often disappear almost as quickly as they arrive. CJC-1295 with DAC was developed to give researchers more time to follow a GHRH-related message and observe how the wider growth-hormone system responds.
Its main feature is the DAC modification, which helps the peptide remain available for longer than shorter GHRH-related compounds.
What Makes DAC Different
DAC helps CJC-1295 connect with albumin, a protein that naturally stays in circulation for a longer period.
You can imagine albumin as a carrier that gives the peptide a longer journey through the research system. The basic message remains connected with GHRH, but it does not disappear as quickly.
CJC-1295 with DAC is not growth hormone itself. It represents an earlier signal linked with the process that normally tells the pituitary gland to release growth hormone.
Why Timing Matters
Natural growth-hormone signaling does not usually happen as one constant message. It rises and falls in pulses.
CJC-1295 with DAC creates a longer-lasting research signal, allowing scientists to compare prolonged GHRH-related activity with shorter, more pulse-like signals.
A longer signal is not automatically better or stronger. It simply gives researchers a different view of the same wider hormonal system.
Future Research Potential
Future research may help explain how longer GHRH-related signaling is connected with growth-hormone rhythm, IGF-1, body composition, fat metabolism, muscle maintenance and recovery-related processes.
Scientists may also learn whether a longer signal offers different research possibilities than shorter GHRH-related peptides. These areas are still being explored and should not be viewed as guaranteed effects.
Important Notice
For research use only. Not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications. Before use, carefully review the Safety Data Sheet (SDS/MSDS – KBU). Intended only for experienced researchers and professionals familiar with the safe handling of research-grade materials.
Technical Questions (FAQ)
DAC stands for Drug Affinity Complex. It is a modification that helps the peptide connect with albumin, a natural carrier protein found in the body. This allows CJC-1295 to remain available for a longer period.
No. CJC-1295 with DAC contains the modification that gives it a longer research profile. Products described as CJC-1295 No DAC are generally associated with shorter GHRH-related signaling. However, the exact peptide used under the No DAC name may vary, so its identity should always be confirmed through the current Certificate of Analysis.
No. This product is intended only for controlled research use. It is not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications.
Lyophilization removes water from the material and helps maintain stability during storage. Exact storage, handling and preparation of the solution should always follow the product documentation and Safety Data Sheet.
Scientific Studies and Development Sources
Additional information
| CAS | 446262-90-4 |
|---|
